Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipsen Pharmaceuticals
Manufacturing
CDMO Quotient extends Ipsen supply deal for rare disease drug
Quotient Sciences extended its deal with Ipsen to manufacture the only medication approved by the FDA to treat fibrodysplasia ossificans progressiva.
Joseph Keenan
Mar 2, 2026 11:00am
Fierce Biotech
Zydus' phase 3 win tees up filing to challenge Gilead and Ipsen
Aug 29, 2025 10:59am
Ipsen's Onivyde turns in positive results in pancreatic cancer
Jan 20, 2023 11:21am
'The Top Line': FDA's drug approval, plus this week's headlines
Jan 13, 2023 6:00am
Ipsen's Onivyde pushes for earlier pancreatic cancer
Nov 9, 2022 12:16pm
PanCAN taps Mindy Kaling as face of 'PurpleStride' fundraiser
Mar 1, 2022 9:40am
